TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Cand Pharm C. Cristoffersen AS
Closing information (x1000 SEK)
| Closing information | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Turnover |
191,588
|
170,988
|
155,234 |
| Financial expenses |
251
|
251
|
282 |
| Earnings before taxes |
10,972
|
11,700
|
6,961 |
| Total assets |
87,609
|
73,587
|
66,621 |
| Current assets |
68,266
|
55,989
|
47,135 |
| Current liabilities |
27,847
|
22,416
|
23,098 |
| Equity capital |
59,762
|
51,172
|
42,505 |
| - share capital |
2,645
|
2,561
|
2,502 |
| Employees (average) | 49 | ||
| Shareholders | 0 | 0 | 0 |
Financial ratios
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Solvency |
68.2%
|
69.5%
|
63.8% |
| Turnover per employee | 3,168 | ||
| Profit as a percentage of turnover |
5.7%
|
6.8%
|
4.5% |
| Return on assets (ROA) |
12.8%
|
16.2%
|
10.9% |
| Current ratio |
245.1%
|
249.8%
|
204.1% |
| Return on equity (ROE) |
18.4%
|
22.9%
|
16.4% |
| Change turnover |
15,024
|
12,106
|
13,607 |
| Change turnover % |
9%
|
8%
|
10% |
| Chg. No. of employees | 3 | ||
| Chg. No. of employees % | 7% |
Total value of public sale
| Fiscal year | 2019/12 (consolidated) | 2018/12 (consolidated) | 2017/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.